1 1

FDA NDA 018687, NORMODYNE, SCHERING, 08/01/1984

FDA NDA 018687, NORMODYNE, SCHERING, 08/01/1984

$921.22 USD
$921.22 USD
Sale Sold out

Contents: Summary Basis of Approval of LABETALOL HYDROCHLORIDE (NORMODYNE) TABLET ORAL 100MG ; 200MG; 300MG; 400MG for the Applicant SCHERING CORP SUB SCHERING PLOUGH CORP

NDA: 018687
Company: SCHERING
Drug Name: NORMODYNE
Active Ingredients: LABETALOL HYDROCHLORIDE
Strength: 400MG
Dosage Form/Route: TABLET;ORAL
Action Date: 08/01/1984
Marketing Status: Discontinued
Submission Classification: ORIG-1
Action Date: None

311 Pages
View full details
FOIA Pro

This drug has a lot more FDA history than one product page can show

FOIA Pro gives you full-text search across 70,000+ FDA FOIA records, from 2020 through today, plus a monthly monitor tracking new requests as they close.
  • Full-text search across every FDA FOIA log since 2020
  • Warning letters, approval records, and correspondence in one place
  • Monthly FDA FOIA Monitor newsletter, included
  • Cancel anytime, monthly or annual billing
Get FOIA Pro
Live search · FOIA database
Searching related FDA records…
ClosedTypeSubjectOutcome